Niche Biotech Focus CSG specializes in biomacromolecules and nutraceuticals rooted in scientific and clinical research, presenting a clear entry point for partnerships with biotech firms, wellness brands, and academic collaborators seeking novel ingredients and formulations.

Small to Medium Size With 11-50 employees and revenue under one million, there is a focus on nimble, high-touch engagements ideal for strategic account selling, pilot projects, and collaborative product development with larger wellness players seeking agile partners.

Acquisition History CSG was acquired by BioZyme in 2018, indicating a potential preference for integrated solutions or exit-ready partnerships; this history suggests exploring co-development or distribution arrangements with BioZyme and related animal and human health portfolios.

Recent Product Milestone Launch of a human product combining MHB3 Hyaluronan and Amaferm signals capabilities in translational nutraceuticals; opportunities exist to expand into additional human-focused formulations or contract research collaborations to validate novel biomacromolecules.

Technology & Platform Utilizes standard digital and marketing technologies (Google Ads, WordPress, ActiveCampaign, Google Cloud) which can be leveraged to support joint marketing, lead generation, and scalable co-branded campaigns with partner networks in wellness, nutrition, and veterinary spaces.